We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.67%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+221.81%
AUM
$46.3B
AUM Growth
+$3.2B
Cap. Flow
+$2.34B
Cap. Flow %
5.07%
Top 10 Hldgs %
17.9%
Holding
3,541
New
248
Increased
1,836
Reduced
1,143
Closed
207

Sector Composition

Rank Sector Weight
1 Technology 9.28%
2 Healthcare 9.23%
3 Financials 8.81%
4 Industrials 6.85%
5 Communication Services 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KYN icon
1326
Kayne Anderson Energy Infrastructure Fund
KYN
$2.38B
$2.98M 0.01%
158,283
+13,323
+9% +$257K
HSKA
1327
DELISTED
Heska Corp
HSKA
$2.98M 0.01%
29,236
+25,662
+718% +$2.53M
FDC
1328
DELISTED
First Data Corporation
FDC
$2.98M 0.01%
163,773
+27,126
+20% +$454K
BGB
1329
Blackstone Strategic Credit 2027 Term Fund
BGB
$502M
$2.97M 0.01%
186,680
-127,699
-41% -$2.06M
KEYS icon
1330
Keysight
KEYS
$57.4B
$2.97M 0.01%
+76,291
New +$2.88M
WAB icon
1331
Wabtec
WAB
$50B
$2.97M 0.01%
32,429
+410
+1% +$34.2K
GBAB
1332
Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust
GBAB
$386M
$2.96M 0.01%
130,084
-2,962
-2% -$67.3K
ATAXZ
1333
DELISTED
AMERICA FIRST TAX EXEMT INV LP
ATAXZ
$2.96M 0.01%
497,191
-8,643
-2% -$51.4K
MINI
1334
DELISTED
Mobile Mini Inc
MINI
$2.95M 0.01%
98,811
+4,910
+5% +$141K
ALLE icon
1335
Allegion
ALLE
$14.3B
$2.94M 0.01%
36,298
+2,985
+9% +$234K
XLIS
1336
DELISTED
POWERSHARES S&P SMALLCAP INDUSTRIALS PORTFOLIO
XLIS
$2.94M 0.01%
51,975
+4,805
+10% +$272K
BNS icon
1337
Scotiabank
BNS
$108B
$2.94M 0.01%
48,819
-1,840
-4% -$105K
CC icon
1338
Chemours
CC
$2.19B
$2.92M 0.01%
76,983
+58,767
+323% +$2.32M
CFO icon
1339
VictoryShares US 500 Enhanced Volatility Wtd ETF
CFO
$424M
$2.92M 0.01%
66,212
+27,048
+69% +$1.17M
CVY icon
1340
Invesco Zacks Multi-Asset Income ETF
CVY
$125M
$2.92M 0.01%
139,190
-1,243
-0.9% -$25.9K
XPH icon
1341
State Street SPDR S&P Pharmaceuticals ETF
XPH
$504M
$2.91M 0.01%
67,626
-9,055
-12% -$382K
NZF icon
1342
Nuveen Municipal Credit Income Fund
NZF
$2.42B
$2.91M 0.01%
194,978
-22,869
-10% -$338K
RSPD icon
1343
Invesco S&P 500 Equal Weight Consumer Discretionary ETF
RSPD
$334M
$2.91M 0.01%
94,011
+54,651
+139% +$1.68M
EELV icon
1344
Invesco S&P Emerging Markets Low Volatility ETF
EELV
$428M
$2.9M 0.01%
121,002
+24,364
+25% +$574K
GGN
1345
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$795M
$2.9M 0.01%
526,165
-36,405
-6% -$206K
IXN icon
1346
iShares Global Tech ETF
IXN
$8.77B
$2.88M 0.01%
132,138
+5,064
+4% +$110K
POT
1347
DELISTED
Potash Corp Of Saskatchewan
POT
$2.88M 0.01%
176,516
-77,722
-31% -$1.29M
PAGP icon
1348
Plains GP Holdings
PAGP
$4.96B
$2.87M 0.01%
109,654
-28,134
-20% -$786K
IART icon
1349
Integra LifeSciences
IART
$1.38B
$2.87M 0.01%
52,592
+2,311
+5% +$110K
HQY icon
1350
HealthEquity
HQY
$8.73B
$2.86M 0.01%
57,466
+14,355
+33% +$671K

Similar funds

Raymond James & Associates's Q2 2017 Portfolio in Review

As of Q2 2017, Raymond James & Associates held 3,541 positions worth $46.3B, up 7.4% from $43.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Raymond James & Associates deployed $2.34B of net new capital in Q2 2017, opening 248 new positions and adding to 1,836 existing holdings. Its largest new stake was DXC Technology: 324,843 shares worth $21.6M.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, down from 9.6% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Novartis, an estimated $53.7M trimmed.

  • Raymond James & Associates's largest Q2 2017 buy was DXC Technology: 324,843 shares worth $21.6M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2017, an estimated $308M increase.
  • Raymond James & Associates's biggest Q2 2017 reduction was Novartis, cutting an estimated $53.7M.
  • Raymond James & Associates fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $24.9M.
  • Raymond James & Associates's ten largest holdings make up 18% of its $46.3B portfolio in Q2 2017.
  • Raymond James & Associates opened 248 new positions and closed 207 in Q2 2017.
  • Raymond James & Associates's portfolio value rose 7.4% quarter-over-quarter to $46.3B.

Based on Raymond James & Associates's 13F filing for Q2 2017, filed 14 Aug 2017.